As Expected, Tripos Officials Initiate Plan to Buy Discovery Research Business | GenomeWeb
NEW YORK (GenomeWeb News) — As expected, a group of Tripos senior executives will buy the company’s Discovery Research subsidiary for £548,000 ($1.1 million), according to a binding letter of intent the company filed with the US Securities and Exchange commission on April 12.
The company said in March that if a planned sale of the business to Provid Pharmaceuticals were to fall through then some of its management might buy the group themselves.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.